Ulenistamab

DB18291InvestigationalProtein Based Therapies

Ulenistamab: Overview.

Mechanism
Curator reviewed
Also known as
Immunoglobulin g1, anti-(human pancreatic adenocarcinoma up-regulated factor) (human-mus musculus monoclonal pbp1510 .gamma.1-chain), disulfide with human-mus musculus monoclonal pbp1510 .kappa.-chain, dimer
Code names
PBP-1510

Resolves to

Compound
UNIIHX998WER5ACAS2415259-90-2
Targets
Q96DA0ZG16B

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Ulenistamab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In